Published in J Infect Dis on February 01, 1984
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol (1994) 2.68
The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol (1995) 2.45
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest (1988) 2.05
Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A (1997) 1.85
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol (1995) 1.69
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol (1996) 1.60
Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol (1995) 1.52
Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci U S A (1990) 1.49
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest (1990) 1.46
Replication of human cytomegalovirus in human peripheral blood T cells. J Virol (1986) 1.45
A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol (1996) 1.37
The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol (2007) 1.35
Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900. J Virol (1998) 1.29
The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. J Virol (1990) 1.27
Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus. J Virol (1985) 1.25
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol (2003) 1.18
Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness. J Virol (1988) 1.13
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest (1992) 1.12
Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J Virol (1995) 1.05
Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J Virol (2003) 1.01
Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells. J Clin Invest (1985) 0.99
Detection of cytomegalovirus from blood leukocytes separated by sepracell-MN and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1988) 0.97
Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro. J Virol (1986) 0.97
The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. J Virol (1997) 0.92
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Acquisition of cytomegalovirus infection: an update. Clin Microbiol Rev (1989) 0.91
Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol (2004) 0.90
Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. J Virol (2006) 0.90
Activity of the cytomegalovirus genome in the presence of PPi analogs. J Virol (1985) 0.87
Suppression of monocyte functions by human cytomegalovirus. Immunology (1989) 0.87
Murine cytomegalovirus infection of cultured mouse embryos. Am J Pathol (1987) 0.87
In situ hybridization for cytomegalovirus DNA in AIDS patients. Am J Pathol (1988) 0.86
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84
Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication. PLoS Pathog (2013) 0.82
Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8. J Virol (1997) 0.82
Comparison of the Histopaque-1119 method with the Plasmagel method for separation of blood leukocytes for cytomegalovirus isolation. J Clin Microbiol (1992) 0.75
The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication. PLoS Pathog (2017) 0.75
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut (2000) 3.69
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol (1991) 3.15
Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand (1991) 2.29
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol (2006) 2.18
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med (2000) 2.09
Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut (1986) 1.87
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res (1997) 1.55
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden. Cancer Causes Control (1993) 1.51
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol (1993) 1.43
The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol (1987) 1.37
Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer (1978) 1.35
Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol (1986) 1.31
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer (2001) 1.29
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol (1997) 1.22
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst (2000) 1.21
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A (1987) 1.21
Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cell Immunol (1978) 1.20
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial. J Clin Oncol (1990) 1.19
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol (1999) 1.16
A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia. Br J Haematol (1992) 1.16
Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol (1999) 1.13
Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia (2007) 1.11
Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res (1994) 1.10
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol (2002) 1.09
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood (1985) 1.08
Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer (1976) 1.06
Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood (1984) 1.06
KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Leukemia (1995) 1.05
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol (2001) 1.04
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. J Clin Oncol (1984) 0.98
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer (2000) 0.94
Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis (1999) 0.93
Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy. Gut (2005) 0.93
Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut (1987) 0.93
Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy. Cancer Treat Rev (1982) 0.92
Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County. Dis Colon Rectum (1990) 0.91
Laminin-5 gamma 2 chain expression correlates with unfavorable prognosis in colon carcinomas. Anal Cell Pathol (2001) 0.91
Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors. Ann Oncol (2003) 0.90
Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy. Cancer (1976) 0.89
Preoperative short-term radiotherapy in rectal carcinoma. A preliminary report of a prospective randomized study. Cancer (1985) 0.88
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer. J Clin Oncol (1996) 0.88
DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology (1992) 0.88
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst (2001) 0.88
Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis. Int J Colorectal Dis (2008) 0.88
EBV infection of mitogen-stimulated human B lymphocytes. Int J Cancer (1981) 0.87
Early interactions between human cytomegalovirus and cells. Arch Virol (1984) 0.87
Kala-azar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis. Acta Paediatr (1993) 0.87
Ropivacaine gel in active distal ulcerative colitis and proctitis -- a pharmacokinetic and exploratory clinical study. Aliment Pharmacol Ther (1996) 0.87
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up. Ann Oncol (2007) 0.86
Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report. Cancer Treat Rep (1979) 0.86
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer. Cancer (1992) 0.86
Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy. Cancer (1992) 0.86
Laminin 5 gamma 2 chain expression: a marker of early invasiveness in colorectal adenomas. Mol Pathol (2003) 0.86
Adsorption of purified human cytomegalovirus and induction of early antigens in different cells. J Med Virol (1982) 0.85
High-resolution computed tomography in the diagnosis of miliary tuberculosis. Chest (1992) 0.85
Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. Scand J Gastroenterol (1979) 0.85
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. J Clin Oncol (1998) 0.84
Myocardial rupture with cardiac tamponade as a lethal early manifestation of acute myeloblastic leukemia. Cancer (1982) 0.83
Gastroesophageal reflux in healthy subjects. Significance of endoscopic findings, histology, age, and sex. Scand J Gastroenterol (1999) 0.83
Are there factors preventing cancer development during embryonic life? Oncodev Biol Med (1983) 0.83
Evidence for immunosurveillance in intestinal premalignant lesions. Scand J Immunol (2010) 0.83
Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study. Cancer (1992) 0.83
Acetazolamide-associated aplastic anaemia. J Intern Med (1990) 0.83
Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein. Int J Cancer (1995) 0.82
Hyperplastic foveolar gastropathies and hyperplastic foveolar gastritis. APMIS (1997) 0.82
Diagnoses in patients with severe pancytopenia suspected of having aplastic anemia. Eur J Haematol (1990) 0.82
KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp Hematol (1992) 0.82
Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer. Semin Oncol (1986) 0.82
Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience. Clin Obstet Gynaecol (1983) 0.81
Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells. J Exp Med (1984) 0.81
Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut (1991) 0.81
Acute leukaemia in a defined geographic area--incidence, clinical history and prognosis. Scand J Haematol (1984) 0.80
DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Mod Pathol (1995) 0.80
Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol (1991) 0.80
Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute non-lymphocytic leukaemia. Br Med J (Clin Res Ed) (1981) 0.80
Cisplatin pharmacokinetics in a patient with renal dysfunction. Med Pediatr Oncol (1978) 0.80
A study of the reproducibility of the diagnostic criteria for acute leukaemia. Scand J Haematol (1983) 0.79
Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep (1986) 0.79
Modulation of potassium channels by dopamine in rat pituitary lactotrophs: a role in the regulation of prolactin secretion? Soc Gen Physiol Ser (1989) 0.79
Reversal of myelofibrosis by hydroxyurea. Eur J Haematol (1990) 0.78
Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group. Cancer Treat Rep (1985) 0.78
Interferon induction in human leukocytes after in vitro exposure to cytomegalovirus or Epstein-Barr virus. Intervirology (1985) 0.78
Detection of germ cell tumor cells in apheresis products using polymerase chain reaction. Clin Cancer Res (1998) 0.78
[Cancer in the ventricular remnant following resection for benign ulcer disease]. Lakartidningen (1981) 0.78
Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function. Cancer (1977) 0.78
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer (1979) 0.78
Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy. Anticancer Res (2005) 0.78
Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia. Bone Marrow Transplant (1995) 0.78
Low-dose ara-C in myelodysplastic syndromes (MDS) and acute leukemia following MDS: proposal for a predictive model. Leuk Lymphoma (1994) 0.77
Metastatic breast cancer: preliminary results with oral hormonal therapy. Semin Oncol (1985) 0.77
DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's-like B-cell lymphoma. APMIS (1994) 0.77
Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomas. Acta Radiol Oncol (1985) 0.77